Active, Not Recruiting
A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes
NCT06993792
- Conditions
- Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +11 more
- Locations
-
- Clinical Research Institute of Arizona (CRI) - Sun City West Sun City West, Arizona, United States
- Novak Clinical Research - Tucson - North La Cholla Boulevard Tucson, Arizona, United States
- Norcal Endocrinology & Internal Medicine San Ramon, California, United States
- Southern California Clinical Research Santa Ana, California, United States